ASX ANNOUNCEMENT 29 October 2026 12 Q1 FY27 Quarterly Activity Report and Appendix 4C Q1 FY27 Highlights: • Global revenue of US$23.1 million, +26% vs prior corresponding period (pcp), reflecting continued commercial momentum. • Quarterly US patient implants of 838, +55% vs pcp, supported by...